# Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

> **NCT03119766** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 370 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Kolofort
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03119766
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-28
- **Primary completion:** 2020-01-11
- **Final completion:** 2020-01-11
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119766, "Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03119766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*